Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07063420 · ClinicalTrials.gov registry record · NA
Patient Centered Multi-Agent Decision Support System (PCM-DSS) for Healthcare Providers
A NA study of Type 2 Diabetes Treated With Insulin, sponsored by Daniel Chernavvsky, MD.
- Recruiting
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT07063420 is a NA study of Type 2 Diabetes Treated With Insulin that is actively recruiting participants, run by Daniel Chernavvsky, MD. The registered enrollment target is 18 participants, below the 303-participant average among 3 other Type 2 Diabetes Treated With Insulin trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07063420, a NA study of Type 2 Diabetes Treated With Insulin, is actively recruiting participants, sponsored by Daniel Chernavvsky, MD.
- RECRUITING
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
Decision Support System (Software) for multi antidiabetic drug therapy use in type 2 diabetes (T2D).
Conditions Studied
Interventions
- OTHER Continuous Glucose Monitor (CGM) + Patient Centered Multi-Agent Decision Support System (PCM-DSS)
- OTHER Continuous Glucose Monitor (CGM) + Usual Care
Study Locations (1)
Virginia
- University of Virginia Center for Diabetes Technology - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2025-10-28 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07063420
The ClinicalTrials.gov registry entry for NCT07063420 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 303-participant average among 3 other Type 2 Diabetes Treated With Insulin trials with a reported enrollment target (94% lower). The listed sponsor is Daniel Chernavvsky, MD, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type 2 Diabetes Treated With Insulin appearing as the primary indexed condition, and to 2 interventions - of which Continuous Glucose Monitor (CGM) + Patient Centered Multi-Agent Decision Support System (PCM-DSS) is the first listed.
NCT07063420 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT07063420 about?
NCT07063420 is a clinical study titled "Patient Centered Multi-Agent Decision Support System (PCM-DSS) for Healthcare Providers". Decision Support System (Software) for multi antidiabetic drug therapy use in type 2 diabetes (T2D).
What is the current status of trial NCT07063420?
This trial is currently recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2025-10-28. Estimated completion is 2026-07-31.
What conditions does trial NCT07063420 study?
This clinical trial studies the following conditions: Type 2 Diabetes Treated With Insulin.
What interventions are being tested in trial NCT07063420?
The interventions under investigation include: Continuous Glucose Monitor (CGM) + Patient Centered Multi-Agent Decision Support System (PCM-DSS) (OTHER), Continuous Glucose Monitor (CGM) + Usual Care (OTHER).
Who is sponsoring clinical trial NCT07063420?
This trial is sponsored by Daniel Chernavvsky, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07063420 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes Treated With Insulin
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.